Abstract:Topical photodynamic therapy (PDT) is an effective treatment with good cosmetic outcome for intraepithelial neoplasia and inflammatory dermatosis such as psoriasis. These disorders show the same histological appearance of epidermal hyperplasia. Photosensitizing agents are relatively selectively concentrated in tumour cells or proliferating keratinocytes. Basal cell acanthoma (BCA; also known as seborrhoeic keratosis, verruca senilis, senile wart, verruca seborrhoica, benign acanothokeratoma and basal cell papilloma) involves proliferation of basaloid cells, thus PDT offers a potential treatment for this lesion. To our knowledge, there have been no clinical trials to date of PDT in the treatment of BCA. After obtaining ethics committee approval and patients informed consent, 5 patients with 12 lesions were enrolled into the study. The diagnosis of BCA was confirmed by a punch biopsy taken from one of lesions. Topical 5-aminolaevulinic acid (ALA) 5–30% (w ⁄ w) in emulsion (Biosynth AG, Staad, Switzerland) was applied for 6 h before irradiation with red light (wavelength 633 nm, light intensity 126 mW ⁄ cm) from lightemitting diodes (LED) (Omnilux, Altrincham, Cheshire, UK). Each lesion plus a margin of disease-free skin was irradiated 1–3 times successively for 5 min each time. The lesions were photographed on a later day in the week, so that neither the application of the cream nor the occlusion affected assessment. Lesions were evaluated and rated by an observer blinded to the study protocol at 1, 3 and 12 months after initial treatment. Patients scored pain on a visual analogue scale (VAS; 0, no pain; 10, worst pain). The clinical characteristics and treatment response of each patient are summarized in Table 1. Only 3 of 12 lesions showed a minimal response clinically. Thus, in this study, no response was seen with PDT therapy in most cases, either with different cumulative doses or different concentrations of ALA. Although three lesions (patients 4 and 5) had a minimal response, changes in diameter or thickness were slight. This may have been due to the fibrosis in the dermis caused by PDT, confirmed by histological examination. The relative tumour shrinkage resulted in the clinical changes. To some extent, pain reflects response during irradiation; patients with greater pain at the same illumination are likely to have better response, as higher pain scoring represents more severe destruction of local tumour tissue, regardless of lesion location. Although patients with minimal response experienced mild pain compared with patients who had no response, the mean pain scores were

Chapter 3 Photodynamic Therapy

Application of 5‐aminolevulinic Acid‐photodynamic Therapy in Common Skin Diseases

Advances in Photodynamic Therapy for the Treatment of Actinic Keratosis and Nonmelanoma Skin Cancer: A Narrative Review

Photodynamic Therapy of Non-Melanoma Skin Malignancies with Topical Delta-Amino Levulinic Acid - Diagnostic Measurements

Photodynamic therapy systems and applications

Advances in the Treatment of Skin Diseases with Δ-Aminolevulinic Acid-Based Photodynamic Therapy

Advanced Light Source Technologies for Photodynamic Therapy of Skin Cancer Lesions

Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers

Photodynamic Therapy for Cancer: Mechanisms, Photosensitizers, Nanocarriers, and Clinical Studies.

Photodynamic Therapy: Superficial and Interstitial Illumination.

Photodynamic Therapy (PDT): PDT Mechanisms

Neoplasia treated by topical photodynamic therapy with variable irradiation dose and concentration of photosensitizer

Photodynamic Therapy For Human Malignancies With Superficial And Interstitial Illumination

Combination of photodynamic therapy and immunotherapy - evolving role in dermatology

Photodynamic Therapy for Field Cancerization in the Skin: Where Do We Stand?

Photodynamic Therapy: Current Status and Future Directions

Topical 5-Aminolevulinic Acid Photodynamic Therapy in the Treatment of Photoaging

Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation.

Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions

[Photodynamic therapy in dermatology, other indications and perspectives]

Photodynamic therapy for the treatment of 18 cases of skin tumors